Mark Opdam

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 6

Top Topics

Metastatic Colorectal Cancer

Top Venues

The Journal of pathology

British journal of cancer

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

EMBO molecular medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Gregory Verghese, Mengyuan Li, Fangfang Liu, Amit Lohan, Nikhil Cherian Kurian, Swati Meena, Patrycja Gazinska, Aekta Shah, Aasiyah Oozeer, Terry Chan, Mark Opdam, Sabine Linn, Cheryl Gillett, Elena Alberts, Thomas Hardiman, Samantha Jones, Selvam Thavaraj, J Louise Jones, Roberto Salgado, Sarah E Pinder, Swapnil U Rane, Amit Sethi, Anita Grigoriadis
Multiscale deep learning framework captures systemic immune features in lymph nodes predictive of triple negative breast cancer outcome in large-scale studies. The Journal of pathology (2023)
Jinhyuk Bhin, Julia Yemelyanenko, Xue Chao, Sjoerd Klarenbeek, Mark Opdam, Yuval Malka, Liesbeth Hoekman, Dinja T Kruger, Onno B Bleijerveld, Chiara S Brambillasca, Justin Sprengers, Bjorn Siteur, Stefano Annunziato, Matthijs J van Haren, Nathaniel I Martin, Marieke van de Ven, Dennis Peters, Reuven Agami, Sabine C Linn, Epie Boven, A F Maarten Altelaar, Jos Jonkers, Daniel Zingg, Lodewyk F A Wessels
MYC is a clinically significant driver of mTOR inhibitor resistance in breast cancer. The Journal of experimental medicine 220 (11) (2023)
Stefan Prekovic, Theofilos Chalkiadakis, Merel Roest, Daniel Roden, Catrin Lutz, Karianne Schuurman, Mark Opdam, Liesbeth Hoekman, Nina Abbott, Tanja Tesselaar, Maliha Wajahat, Amy R Dwyer, Isabel Mayayo-Peralta, Gabriela Vilas Bôas Gomez, A F Maarten Altelaar, Roderick Beijersbergen, Gyorffy Balazs, Leonie Young, Sabine Linn, Jos Jonkers, Wayne D Tilley, Theresa E Hickey, Damir Varešlija, Alexander Swarbrick, Wilbert Zwart
Luminal breast cancer identity is determined by loss of glucocorticoid receptor activity. EMBO molecular medicine (2023)
Leonora W de Boo, Katarzyna Jóźwiak, Heikki Joensuu, Henrik Lindman, Susanna Lauttia, Mark Opdam, Charlaine van Steenis, Wim Brugman, Roelof J C Kluin, Philip C Schouten, Marleen Kok, Petra M Nederlof, Michael Hauptmann, Sabine C Linn
Adjuvant capecitabine-containing chemotherapy benefit and homologous recombination deficiency in early-stage triple-negative breast cancer patients. British journal of cancer 126 (10) (2022)
Vincent M T de Jong, Yuwei Wang, Natalie D Ter Hoeve, Mark Opdam, Nikolas Stathonikos, Katarzyna Jóźwiak, Michael Hauptmann, Sten Cornelissen, Willem Vreuls, Efraim H Rosenberg, Esther A Koop, Zsuzsanna Varga, Carolien H M van Deurzen, Antien L Mooyaart, Alicia Córdoba Iturriagagoitia, Emma J Groen, Joost Bart, Stefan M Willems, Vasiliki Zolota, Jelle Wesseling, Anna Sapino, Ewa Chmielik, Aleš Ryška, Annegien Broeks, Adri C Voogd, Sherene Loi, Stefan Michiels, Gabe S Sonke, Elsken van der Wall, Sabine Siesling, Paul J van Diest, Marjanka K Schmidt, Marleen Kok, Gwen M H E Dackus, Roberto Salgado, Sabine C Linn
Prognostic Value of Stromal Tumor-Infiltrating Lymphocytes in Young, Node-Negative, Triple-Negative Breast Cancer Patients Who Did Not Receive (neo)Adjuvant Systemic Therapy. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 40 (21) (2022)
Lennart Kester, Danielle Seinstra, Annelot G J van Rossum, Claire Vennin, Marlous Hoogstraat, Daphne L van der Velden, Mark Opdam, Erik D van Werkhoven, Kerstin Hahn, Iris Nederlof, Ester H Lips, Ingrid A M Mandjes, A Elise van Leeuwen-Stok, Sander Canisius, Harm D R van Tinteren, Alex L T Imholz, Johanneke E A Portielje, Monique E M M Bos, Sandra D Bakker, Emiel J T Rutgers, Hugo Mark Horlings, Jelle Wesseling, Emile E Voest, Lodewyk F A Wessels, Marleen Kok, Hendrika M Oosterkamp, Alexander van Oudenaarden, Sabine C Linn, Jacco van Rheenen
Differential Survival and Therapy Benefit of Patients with Breast Cancer Are Characterized by Distinct Epithelial and Immune Cell Microenvironments. Clinical cancer research : an official journal of the American Association for Cancer Research 28 (5) (2022)